COVID-19的全球影响:历史发展,分子表征,药物发现和未来方向
Aboagye Kwarteng Dofuor1, Naa Kwarley-Aba Quartey2, Angelina Fathia Osabutey3
1Department of Biological Sciences, School of Natural and Environmental Sciences, University of Environment and Sustainable Development, Somanya, Ghana.
Clinical pathology (Thousand Oaks, Ventura County, Calif.)
|December 25, 2023
概括
由SARS-CoV-2引起的COVID-19大流行,对全球产生了严重的影响. 研究正在推进疫苗和诊断,探索来自昆虫和植物来源的新型治疗点.
科学领域:
- 病毒学 病毒学
- 流行病学 流行病学
- 生物化学 生物化学
背景情况:
- 2019年12月严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2) 的出现导致了COVID-19大流行,造成了广泛的健康和经济破坏.
- 一种封装的正链RNA病毒SARS-CoV-2对社会产生了深远的影响,加剧了医疗保健差异并影响了心理健康.
- 尽管没有确定的治疗方法,但疫苗开发和诊断方面取得了重大进展,以对抗该病毒.
研究的目的:
- 为 COVID-19 提供全面的历史概述.
- 详细介绍SARS-CoV-2的分子和生物化学特征.
- 探索来自昆虫和植物来源的潜在抗SARS-CoV-2贡献.
主要方法:
- 对COVID-19发展的历史数据的审查.
- 对SARS-CoV-2分子和生物化学性质的分析.
- 对抗病毒性质的天然产品来源的调查.
主要成果:
- 开发多种COVID-19疫苗候选人和快速诊断工具.
- 鉴定SARS-CoV-2的病毒结构和复制机制.
- 探索昆虫和植物衍生化合物作为潜在的治疗方法.
结论:
- 疫苗和诊断对于减轻COVID-19的传播,严重程度和死亡率至关重要.
- 了解SARS-CoV-2的分子和生物化学方面是开发有效治疗的关键.
- 对自然来源的进一步研究可能会产生新的抗SARS-CoV-2药物.
更多相关视频
相关概念视频
Drug Discovery: Overview
7.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.9K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Structure-Activity Relationships and Drug Design
727
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
727
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Targets for Drug Action: Overview
6.3K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.3K


